Why the study?
Does survival and tricuspid regurgitation reduction after Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) differ between patients with atrial versus ventricular secondary tricuspid regurgitation?
Does survival and tricuspid regurgitation reduction after Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) differ between patients with atrial versus ventricular secondary tricuspid regurgitation?
In patients undergoing transcatheter edge-to-edge repair for secondary tricuspid regurgitation, an atrial etiology is associated with better 12-month survival compared to a ventricular etiology.
Etiology may influence post-T-TEER survival; leaves open whether stratification should guide selection or trial design.
In a real-world, multicentre registry, T-TEER was effective in reducing TR grade in both ASTR and VSTR. At 12-month follow-up, ASTR showed better survival than VSTR.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: